World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
61
Citations
16522
World Ranking
3206
National Ranking
1501

Best Publications

  • Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

    Peter A. McSweeney;Peter A. McSweeney;Peter A. McSweeney;Dietger Niederwieser;Dietger Niederwieser;Dietger Niederwieser;Judith A. Shizuru;Judith A. Shizuru;Judith A. Shizuru;Brenda M. Sandmaier;Brenda M. Sandmaier;Brenda M. Sandmaier

  • Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases

    Dietger Niederwieser;Michael Maris;Judith A. Shizuru;Effie Petersdorf

  • The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases.

    Irving L. Weissman;Judith A. Shizuru

  • Tolerance and Chimerism after Renal and Hematopoietic-Cell Transplantation

    John D. Scandling;Stephan Busque;Sussan Dejbakhsh-Jones;Claudia Benike

  • CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

    Jay Y. Spiegel;Shabnum Patel;Lori Muffly;Nasheed M. Hossain

  • Ablative Tumor Radiation Can Change the Tumor Immune Cell Microenvironment to Induce Durable Complete Remissions.

    Alexander Filatenkov;Jeanette Baker;Antonia M.S. Mueller;Justin Kenkel

  • Loss of pancreatic islet tolerance induced by β-cell expression of interferon-γ

    N Sarvetnick;J Shizuru;D Liggitt;D Liggitt;L Martin

  • Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes

    JA Shizuru;C Taylor-Edwards;BA Banks;AK Gregory

  • Protective conditioning for acute graft-versus-host disease.

    Robert Lowsky;Tsuyoshi Takahashi;Yin Ping Liu;Sussan Dejbakhsh-Jones

  • Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation.

    Heather G. Shilling;Karina L. McQueen;Nathalie W. Cheng;Judith A. Shizuru

  • Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes.

    Jonathan T. Sockolosky;Eleonora Trotta;Giulia Parisi;Lora Picton

  • Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.

    Mohamed L. Sorror;Barry E. Storer;Brenda M. Sandmaier;Michael Maris

  • Treatment for Acute Myelogenous Leukemia by Low-Dose, Total-Body, Irradiation-Based Conditioning and Hematopoietic Cell Transplantation From Related and Unrelated Donors

    Ute Hegenbart;Dietger Niederwieser;Brenda M. Sandmaier;Michael B. Maris

  • Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation.

    Maria T Millan;Judith A Shizuru;Petra Hoffmann;Sussan Dejbakhsh-Jones

  • Expansion of cytolytic CD8+ natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon γ production

    Jeanette Baker;Michael R. Verneris;Maki Ito;Judith A. Shizuru

  • Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma

    Steven M. Horwitz;Robert S. Negrin;Karl G. Blume;Sheila Breslin

  • Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia

    Boglarka Gyurkocza;Rainer Storb;Barry E. Storer;Thomas R. Chauncey

  • Chimerism, Graft Survival, and Withdrawal of Immunosuppressive Drugs in HLA Matched and Mismatched Patients After Living Donor Kidney and Hematopoietic Cell Transplantation

    J. D. Scandling;S. Busque;J. A. Shizuru;R. Lowsky

  • Islet allograft survival after a single course of treatment of recipient with antibody to L3T4.

    JA Shizuru;AK Gregory;CT Chao;CG Fathman

  • TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors.

    Holbrook E. Kohrt;Brit B. Turnbull;Kartoosh Heydari;Judith A. Shizuru

Frequent Co-Authors

Robert S. Negrin
Robert S. Negrin Stanford University
Brenda M. Sandmaier
Brenda M. Sandmaier Fred Hutchinson Cancer Research Center
David G. Maloney
David G. Maloney Fred Hutchinson Cancer Research Center
Rainer Storb
Rainer Storb Fred Hutchinson Cancer Research Center
Irving L. Weissman
Irving L. Weissman Stanford University
Samuel Strober
Samuel Strober Stanford University
Karl G. Blume
Karl G. Blume Stanford University
Barry E. Storer
Barry E. Storer Fred Hutchinson Cancer Research Center
Michael A. Pulsipher
Michael A. Pulsipher University of Utah
Richard T. Maziarz
Richard T. Maziarz Oregon Health & Science University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Judith A. Shizuru

Recently Published Articles